Standardized Double-Linked Type-A Polymers for Glucose Sensitivity, Healthy Insulin Function, and Metabolic Wellness
Clinical Overview: The Gold Standard in Cinnamon Supplementation
Whole cinnamon bark contains hundreds of bioactive phytonutrients, but unrefined cinnamon powder carries significant amounts of fat-soluble compounds—most notably cinnamaldehyde and hepatotoxic coumarin. Cinnulin PF® 500 mg solves this challenge through a patented 100% aqueous (water-only) extraction process developed in partnership with scientists at the United States Department of Agriculture (USDA-ARS).
By isolating only the water-soluble fraction of Cinnamomum burmannii, Cinnulin PF® concentrates the verified active compounds—specifically doubly linked Type-A procyanidin polymers (trimers and tetramers)—while virtually eliminating coumarin (under 0.7%) and lipid-soluble essential oils. At a research-backed 500 mg daily intake, Cinnulin PF® delivers targeted metabolic support to help maintain healthy blood sugar, systolic blood pressure, and body composition already within a normal range.
Biochemical Mechanism: How Type-A Polymers Support Cellular Glucose Uptake
The bioactive polyphenols in Cinnulin PF® act at the molecular level to optimize the physiological cascade governing glucose uptake:
Insulin Receptor Autophosphorylation: Type-A polymers stimulate the tyrosine kinase activity of the insulin receptor ß-subunit, amplifying intracellular signaling cascades when insulin binds to its receptor.
PI3K and Akt Pathway Upregulation: By activating phosphatidylinositol 3-kinase (PI3K), Cinnulin PF® promotes downstream Akt signaling, which is essential for healthy glycemic regulation and vascular tone.
GLUT4 Translocation: Activation of the PI3K-Akt cascade prompts the mobilization of glucose transporter type 4 (GLUT4) storage vesicles to the cell surface in skeletal muscle and adipose tissue, clearing circulating glucose without overtaxing pancreatic beta cells.
Inhibition of PTP1B: Cinnulin PF® constituents downregulate Protein Tyrosine Phosphatase 1B (PTP1B), a regulatory enzyme that dephosphorylates and deactivates the insulin receptor. Inhibiting PTP1B sustains healthy insulin signaling longer.
Antioxidant and Endothelial Protection: The water-soluble polyphenols scavenge reactive oxygen species (ROS), protecting vascular endothelial cells from the oxidative stress often associated with carbohydrate metabolism.
Peer-Reviewed Human Clinical Research
Unlike generic "cinnamon bark powder" supplements that rely entirely on anecdotal claims, Cinnulin PF® is validated by double-blind, randomized, placebo-controlled clinical trials:
1. Metabolic Syndrome & Body Composition (Ziegenfuss et al., 2006)
In a 12-week randomized, double-blind, placebo-controlled trial involving 22 pre-diabetic men and women with metabolic syndrome features, subjects receiving 500 mg/day of Cinnulin PF® demonstrated:
An 8.4% reduction in fasting blood glucose (from 116.3 ± 12.8 mg/dL to 106.5 ± 20.1 mg/dL; p < 0.01), with 83% of participants showing glycemic improvements versus 33% on placebo.
A statistically significant 3.8% reduction in systolic blood pressure (from 133 ± 14 mm Hg to 128 ± 18 mm Hg; p < 0.001).
A +1.1% increase in lean body mass along with a statistically significant 0.7% decrease in body fat percentage without changes in caloric intake.
Citation: Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr. 2006;3(2):45-53.
2. Biomarkers of Oxidative Stress & Antioxidant Status (Roussel et al., 2009)
In a randomized, placebo-controlled study evaluating overweight adults with impaired fasting glucose, 12 weeks of aqueous cinnamon extract supplementation (500 mg/day) led to significant improvements in antioxidant status:
Significant increases in ferric-reducing antioxidant power (FRAP).
Marked reductions in plasma malondialdehyde (MDA), a primary indicator of lipid peroxidation and systemic oxidative damage.
Citation: Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr. 2009;28(1):16-21.
Because insulin resistance drives ovarian hyperandrogenism, researchers evaluated standardized water-soluble cinnamon extract in women with Polycystic Ovary Syndrome (PCOS). Supplementation over 6 months demonstrated significantly increased menstrual regularity (median 0.75 vs. 0.25 cycles/month; p = 0.0085) and improved homeostatic model assessment of insulin resistance (HOMA-IR), confirming cinnamon's therapeutic role in metabolic-hormonal pathways.
Citation: Kort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2014;211(5):487.e1-6.
The Critical Difference: Cinnulin PF® vs. Common Cinnamon Bark Powder
When evaluating cinnamon extracts, safety is just as vital as potency. Standard grocery-store cassia cinnamon and raw powdered supplements carry distinct physiological drawbacks when ingested in therapeutic quantities daily:
Parameter
Raw Cassia / Ceylon Powder
Generic Solvent Extracts
Patented Cinnulin PF® 500 mg
Bioactive Standardization
Variable / Undefined
Inconsistent (often standardized to cinnamaldehyde)
Standardized to ≥3% Doubly Linked Type-A Polymers
Coumarin Concentration
High (up to 1% or 7,000 ppm in cassia); hepatotoxic risk
May cause mucosal irritation due to essential oils
Variable
Gentle on the stomach; fat-soluble irritants removed
Complete Ingredient Listing & Supplement Facts
Formulated to strict cGMP pharmaceutical standards. Each batch is verified for identity, potency, and purity via High-Performance Liquid Chromatography (HPLC).
Supplement Facts
Serving Size: 2 Vegetarian Capsules
Servings Per Container: 30
Amount Per Serving
% Daily Value
Cinnulin PF® Cinnamon Bark Water Extract (Cinnamomum burmannii) (Standardized to contain ≥3% Type-A Polymers)
Free Of: Wheat, gluten, soy, milk, egg, fish, shellfish, tree nuts, peanuts, artificial colors, flavors, or chemical preservatives. Non-GMO, 100% Vegan, and Kosher certified.
Suggested Usage, Timing & Safety Considerations
Suggested Use: As a dietary supplement for adults, take two (2) capsules daily, preferably one (1) capsule 15 to 30 minutes prior to your two largest carbohydrate-containing meals with an 8 oz glass of water, or as recommended by your qualified healthcare professional.
Healthcare Professional Advisory (YMYL Precaution): If you have diabetes, hypoglycemia, or are currently taking prescription medications that affect blood glucose (such as metformin, glipizide, or insulin), monitor blood glucose levels closely. Cinnamon polyphenols enhance insulin sensitivity; concurrent use may exert additive hypoglycemic effects. Do not use if pregnant, lactating, or if you have severe pre-existing liver disease without first consulting your physician.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions About Cinnulin PF® 500 mg
What is Cinnulin PF® and how is it different from regular cinnamon?
Cinnulin PF® is a patented, 100% water-soluble extract made from Cinnamomum burmannii bark. Unlike ordinary kitchen cinnamon or whole-bark supplements, Cinnulin PF® uses an advanced aqueous fractionation process that concentrates the active, double-linked Type-A procyanidin polymers while filtering out fat-soluble compounds, including coumarin and high-concentration cinnamaldehyde. This ensures you receive a standardized, clinically tested dose of active polymers without gastric or liver stress.
Is Cinnulin PF® safe for daily long-term use regarding coumarin levels?
Yes. Coumarin is a naturally occurring compound in Cassia cinnamon that can cause hepatic toxicity when taken in large, daily amounts. Because coumarin is fat-soluble and Cinnulin PF® uses a water extraction process, coumarin is reduced to trace levels (<0.7%), well below the safety thresholds established by the European Food Safety Authority (EFSA) and the U.S. FDA.
What are Type-A polymers and why are they important?
Type-A polymers are specific doubly linked procyanidin oligomers (primarily trimers and tetramers) found in cinnamon bark. USDA research demonstrated that these specific chemical structures mimic insulin action at the cellular level by promoting the autophosphorylation of insulin receptors, activating PI3-kinase, and prompting GLUT4 translocation to move glucose into cells.
Can I take Cinnulin PF® alongside prescription diabetes medications?
Because Cinnulin PF® supports cellular insulin sensitivity and glucose uptake, taking it alongside prescription hypoglycemic agents (such as insulin, metformin, or sulfonylureas) may produce an additive glucose-lowering effect. You should consult your prescribing physician before combining this supplement with diabetic medication, and monitor your blood sugar levels regularly.
How long does it take to see metabolic benefits with Cinnulin PF® 500 mg?
In peer-reviewed clinical trials, measurable reductions in fasting blood glucose, improvements in systolic blood pressure, and positive shifts in lean body mass were documented after 12 weeks of daily supplementation at 500 mg. However, individual cellular responses vary based on diet, baseline insulin resistance, and physical activity levels.
Does Cinnulin PF® help with Polycystic Ovary Syndrome (PCOS)?
Research published in the American Journal of Obstetrics & Gynecology demonstrated that water-soluble cinnamon extract helped improve insulin sensitivity and significantly increased menstrual regularity over a 6-month period in women diagnosed with PCOS, as glycemic regulation directly influences ovarian androgen production.
When is the best time of day to take Cinnulin PF® capsules?
For best results, take one capsule 15 to 30 minutes before your two highest-carbohydrate meals of the day. This timing aligns the bioactive Type-A polymers with postprandial glucose surges, optimizing cellular glucose uptake and minimizing insulin spikes.
